2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 196

The Pyrin Domain-Only Protein POP1 Inhibits NLRP3-Dependent Inflammatory Disease
Abstract Number: 2408

The Quality of Community-Based Osteoarthritis Care Can be Improved. Results from a Systematic Review and Meta-Analysis
Abstract Number: 3105

The RA Immune System Recreated in Immunodeficient Mice By Thymic Differentiation from RA Patients’ Hematopoietic Stem Cells Exhibits Marked CD4 T Cell Activation and Differentiation
Abstract Number: 611

The Rapid Kinetics of Optimal Treatment with Subcutaneous Methotrexate in Early Inflammatory Arthritis
Abstract Number: 757

The Ratio Between TNF-a and P-Albumin – a Suggested Measure of Disease Activity in SLE
Abstract Number: 1739

The Ratio of Glycated Hemoglobin A1c (HbA1c) to Glycated Albumin (GA) Is Correlated with Ankylosing Spondylitis Disease Activity Score (ASDAS) in Non-Diabetic Patients with Ankylosing Spondylitis
Abstract Number: 976

The Reason of Discontinuation of a First TNF Inhibitor Affects Drug Retention of a Second Anti-TNF Agent in Axial Spondyloarthritis
Abstract Number: 3002

The Regulatory Role of Gammadelta T Cells in Bleomycin-Induced Pulmonary Fibrosis
Abstract Number: 3251

The Relation of Massive Weight Loss to Changes in Knee Pain and Sensitization
Abstract Number: 327

The Relation of Plasma Vitamin K Status to Meniscal Pathology in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 2644

The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis
Abstract Number: 552

The Relationship Between Efficacy and Toxicity in Patients with Rheumatoid Arthritis Receiving Methotrexate in Combination with Adalimumab
Abstract Number: 1415

The Relationship Between Obesity and Low Back Pain and Disability Is Affected By Mood Disorders – a Population-Based, Cross-Sectional Study of Men
Abstract Number: 954

The Relationship Between Osteoarthritis and Cardiovascular Disease: Results from a Population-Based Cohort
Abstract Number: 1381

The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].